# Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques

> **NIH NIH N01** · ADVANCED BIOSCIENCE LABORATORIES, INC. · 2022 · $83,598

## Abstract

The purpose of the Comprehensive Resources for Microbicides and Biomedical Prevention contract is to provide the NIAID with a comprehensive suite of preclinical product development services for candidate products that emerge from investigator-initiated research studies or from collaborations with outside companies or organizations. The Contractor shall provide: 1) Preclinical gap-filling services; 2) HIV animal models supporting product development; 3) Bioanalytical support services; 4) Product manufacturing; and 5) Scientific and quality/regulatory support services.

## Key facts

- **NIH application ID:** 10551010
- **Project number:** 272201600008I-P00005-27200012-1
- **Recipient organization:** ADVANCED BIOSCIENCE LABORATORIES, INC.
- **Principal Investigator:** PETER SILVERA
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $83,598
- **Award type:** —
- **Project period:** 2018-07-16 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10551010

## Citation

> US National Institutes of Health, RePORTER application 10551010, Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques (272201600008I-P00005-27200012-1). Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/grant/nih/10551010. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*